Share through
St. Jude Research Logo
About Us
Care & Treatment
Research
Training
Get Involved
Ways to Give
St. Jude Research
WHY ST. JUDE
Back
WHY ST. JUDE
Robust Databases and Tools
Unparalleled Shared Resources
Translational Innovation
WHY ST. JUDE
DEPARTMENTS & LABS
Back
DEPARTMENTS & LABS
Departments
Labs
CENTERS & INITIATIVES
Back
CENTERS & INITIATIVES
Comprehensive Cancer Center
Institutional Initiatives
Global Impact on Infectious Disease
St. Jude Research Collaboratives
CENTERS & INITIATIVES
CAREERS
Search
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Home
Why St. Jude
Shared Resources & Core Facilities
Technology Licensing
Drug Discovery & Development Tools
Drug Discovery & Development Tools
ARF and HDM2 interaction domains (SJ-01-0016)
Activation of Prodrugs by Carboxylesterase (SJ-98-0001)
Alternate mTOR Pathway (SJ-09-0021)
Assay for ATM Kinase Modulation (SJ-02-0008)
BMP Compounds for treating diseases caused by defective or diminished BMP signaling (Medulloblastoma) - (SJ-15-0008)
CD7 CAR placed in CD7neg memory cells (SJ-15-0020)
Caspase 1 inhibition (SJ-13-0039)
Cells That Lack p19Ink4d and p27Kip1 Activity/p19Ink4d and p27Kip1 Null Mice (SJ-98-0023)
Chimeric gene and protein that can be used to create Optogranules: Light induced stress granules (SJ-18-0010)
DCN1 Inhibitors (SJ-16-0002)
Defects in LC3-associated phagocytosis (LAP) associated with Lupus (SJ-16-0025)
Discovery of a fluorescent vinblastine analog with high affinity to the human pregnane X receptor (hPXR) Ligand (SJ-13-0009)
Discovery of a novel inhibitor of constitutive androstane receptor (CAR) that does not activate pregnane X receptor (PXR) (SJ-14-0039)
FRET Assay for G3BP1 and G3BP2 Inhibitors (SJ-19-0043)
Hematopoietic progenitor cell lines with myeloid and lymphoid potential (SJ-11-0003)
Identification of Toll-like receptor signaling inhibitors (SJ-18-0008)
Improving HSC Engraftment by Inhibiting GASP Genes (SJ-16-0029)
Interaction of Reelin With Very Low Density Lipoprotein (VLDL) Receptor (SJ-98-0045)
LANDO Pathway Disruption for Alzheimer's Disease (SJ-19-0020)
Method for Enhancing Recombinant Antibody Production (SJ-08-0032)
Methods and compositions for the prevention and treatment of hearing loss using CDK2 inhibitors (SJ-14-0028)
Methods for Diagnosing and Treating Learning or Mental Disorders with the SERCA2 Protein and miRNAs that regulate SERCA2 Levels (SJ-10-0003 and SJ-12-0020)
Modulating Non-Canonical Autophagy (LAP) in Myeloid Cells to Suppress Tumors (SJ-17-0019)
Myd88 and CD40 Costimulatory Domains for Chimeric Antigen Receptors (SJ-18-0021)
Ozz, A Protein That Regulates Development and Function of Muscle Cells (SJ-99-0010)
REGNASE-1 Gene Knockout or BATF Overexpression for Improving T-cell Function (SJ-19-0027, SJ-20-0007)
Rapid Cloning of T Cell Receptors (SJ-16-0001)
Regulating p53 Translation and Function (SJ-05-0002)
Respiratory Cell Isolation and Propagation for Pathogen Study (SJ-18-0028)
SCCRO Peptide Inhibitor (SJ-11-0014)
Small Molecule BODIPY FL VH032 Probe for E3 Ligase (SJ-21-0014)
Use of specific retinoid receptor agonists and antagonists as cancer therapies (SJ-14-0011)
miRNAs for Treating Cerebral Ventricle Enlargement in Schizophrenia Patients (SJ-19-0039)
For more information
Contact the
Office of Technology Licensing
:
Phone: (901) 595-2342
Fax: (901) 595-3148
OTL Intellectual Properties Newsletters
More Technologies
Antibodies for Basic Research
Biologics
Diagnostics
Drugs
Other Technologies
Vaccines
Contact Us
View all Shared Resources